FMC Corporation completes acquisition of BioPhero ApS
FMC Corporation (NYSE: FMC) has successfully finalized its acquisition of BioPhero ApS, a Denmark-based pheromone research and production firm. The acquisition agreement was announced on June 29, 2022, and all regulatory approvals have now been satisfied. This strategic move is expected to enhance FMC's capabilities in innovative crop protection solutions, which are crucial for addressing the needs of growers worldwide amidst changing environmental challenges.
- Strengthens FMC's portfolio in crop protection through innovative pheromone technologies.
- Enhances FMC's capabilities for sustainable agriculture amid rising global demands.
- None.
PHILADELPHIA, July 19, 2022 /PRNewswire/ --
FMC Corporation (NYSE: FMC), an agricultural sciences company, today announced that it has completed the closing of its acquisition of BioPhero ApS, a Denmark-based pheromone research and production company. The companies announced the signing of a definitive acquisition agreement on June 29, 2022, and have now satisfied all necessary conditions and regulatory approvals.
About FMC
FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically while protecting the environment. With approximately 6,400 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more and follow us on LinkedIn® and Twitter®.
Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, which are based on management's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These factors include, among other things, the risk factors and other cautionary statements included within FMC's 2021 Form 10-K filed with the SEC as well as other SEC filings and public communications. FMC cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. FMC undertakes no obligation, and specifically disclaims any duty, to update or revise any forward-looking statements to reflect events or circumstances arising after the date on which they were made, except as otherwise required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/fmc-corporation-completes-acquisition-of-biophero-aps-301589023.html
SOURCE FMC Corporation
FAQ
What is the significance of FMC's acquisition of BioPhero?
When was the acquisition of BioPhero by FMC announced?
What does BioPhero specialize in?
What impact will the acquisition have on FMC's operations?
Is the acquisition of BioPhero by FMC finalized?
